The researchers found that the MSCN–PEG–HB5/DOX assembling exhibited significantly higher cellular uptake in the HER2-positive SK-BR-3 breast cancer cell line but not in the normal breast epithelial cell line. This evidence concerns the gene ERBB2 and breast carcinoma.